Zhejiang Int'L Group Co Ltd Total Liabilities
Zhejiang Int'L Group Co Ltd total liabilities. Based on the latest financial reports, Zhejiang Int'L Group Co Ltd (000411) has total liabilities worth CN¥11.95 Billion CNY (≈ $1.75 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 000411 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Zhejiang Int'L Group Co Ltd (1993–2024)
Total liabilities of Zhejiang Int'L Group Co Ltd from 1993 to 2024. This chart illustrates how Zhejiang Int'L Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Zhejiang Int'L Group Co Ltd (000411) long-term investment share to see how much of total assets are deployed in long-term investments.
Zhejiang Int'L Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Int'L Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangsu Jibeier Pharmaceutical Co Ltd
SHG:688566
|
China | CN¥222.75 Million |
|
Jiangsu Canlon Building Materials Co Ltd
SHE:300715
|
China | CN¥3.76 Billion |
|
Episil Holding
TWO:3707
|
Taiwan | NT$3.67 Billion |
|
Tangrenshen Group Co Ltd
SHE:002567
|
China | CN¥11.42 Billion |
|
Odfjell SE
OL:ODF
|
Norway | Nkr1.20 Billion |
|
Dor Alon
TA:DRAL
|
Israel | ILA5.70 Billion |
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
USA | $1.33 Billion |
|
Harim Holdings Co. Ltd
KQ:003380
|
Korea | ₩10.68 Trillion |
Liability Composition Analysis (1993–2024)
This chart breaks down Zhejiang Int'L Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 000411 current and non-current assets.
Liquidity & Leverage Metrics
Zhejiang Int'L Group Co Ltd Total Liabilities Ratios Explained
Zhejiang Int'L Group Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Int'L Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Int'L Group Co Ltd (1993–2024)
The table below shows the annual total liabilities of Zhejiang Int'L Group Co Ltd from 1993 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥9.42 Billion ≈ $1.38 Billion |
+3.23% |
| 2023-12-31 | CN¥9.13 Billion ≈ $1.34 Billion |
-1.65% |
| 2022-12-31 | CN¥9.28 Billion ≈ $1.36 Billion |
+6.31% |
| 2021-12-31 | CN¥8.73 Billion ≈ $1.28 Billion |
+8.52% |
| 2020-12-31 | CN¥8.04 Billion ≈ $1.18 Billion |
+3.16% |
| 2019-12-31 | CN¥7.80 Billion ≈ $1.14 Billion |
+12.86% |
| 2018-12-31 | CN¥6.91 Billion ≈ $1.01 Billion |
-3.75% |
| 2017-12-31 | CN¥7.18 Billion ≈ $1.05 Billion |
+35.68% |
| 2016-12-31 | CN¥5.29 Billion ≈ $774.14 Million |
+14.77% |
| 2015-12-31 | CN¥4.61 Billion ≈ $674.50 Million |
+19.90% |
| 2014-12-31 | CN¥3.84 Billion ≈ $562.55 Million |
+8.22% |
| 2013-12-31 | CN¥3.55 Billion ≈ $519.82 Million |
+16.00% |
| 2012-12-31 | CN¥3.06 Billion ≈ $448.13 Million |
+10.87% |
| 2011-12-31 | CN¥2.76 Billion ≈ $404.19 Million |
+37.58% |
| 2010-12-31 | CN¥2.01 Billion ≈ $293.79 Million |
+33.73% |
| 2009-12-31 | CN¥1.50 Billion ≈ $219.68 Million |
+26.21% |
| 2008-12-31 | CN¥1.19 Billion ≈ $174.06 Million |
+14.80% |
| 2007-12-31 | CN¥1.04 Billion ≈ $151.61 Million |
+11.91% |
| 2006-12-31 | CN¥925.87 Million ≈ $135.48 Million |
+12.78% |
| 2005-12-31 | CN¥820.92 Million ≈ $120.13 Million |
+15.31% |
| 2004-12-31 | CN¥711.94 Million ≈ $104.18 Million |
+20.17% |
| 2003-12-31 | CN¥592.43 Million ≈ $86.69 Million |
-1.75% |
| 2002-12-31 | CN¥603.00 Million ≈ $88.24 Million |
+18.40% |
| 2001-12-31 | CN¥509.30 Million ≈ $74.53 Million |
+107.15% |
| 2000-12-31 | CN¥245.86 Million ≈ $35.98 Million |
-18.12% |
| 1999-12-31 | CN¥300.27 Million ≈ $43.94 Million |
+13.09% |
| 1998-12-31 | CN¥265.52 Million ≈ $38.85 Million |
+7.25% |
| 1997-12-31 | CN¥247.57 Million ≈ $36.23 Million |
+5.39% |
| 1996-12-31 | CN¥234.91 Million ≈ $34.37 Million |
+22.78% |
| 1995-12-31 | CN¥191.33 Million ≈ $28.00 Million |
+72.12% |
| 1994-12-31 | CN¥111.16 Million ≈ $16.27 Million |
+19.50% |
| 1993-12-31 | CN¥93.02 Million ≈ $13.61 Million |
-- |
About Zhejiang Int'L Group Co Ltd
Zhejiang Int'l Group Co.,Ltd. engages in the wholesale and retail of pharmaceuticals and medical devices. It offers chemical drugs, biological products, and Chinese patent medicine. The company was founded in 1950 and is based in Hangzhou, China.